What’s Behind the ‘Architectural Digest’ Decor at LA’s Ketamine Clinics?

Andrew Fiouzi
Andrew Fiouzi is an editor at dot.LA. He was previously a features writer at MEL Magazine where he covered masculinity, tech and true crime. His work has been featured in the Los Angeles Times, Long Reads and Vice, among other publications.
Antonio Ocana (left) sitting down with another person in the Pasithea clinic.
Courtesy of Pasithea

On the stretch of Sunset Boulevard, where the line between West Hollywood and Beverly Hills becomes faint, inside an eight-story, low-rise medical building, wrapped with a 60-foot poster of J.Lo’s pixel-perfect naked body, the ketamine clinic of the near future is preparing for the clinically depressed.

Pasithea is the latest ketamine center to grace Los Angeles. Inside their state-of-the-art, 1,235 square-foot facility, light oak wood walls, the likes of Scandinavian-themed architecture proliferating throughout the city, welcomes patients with the prospect of chic possibilities.


“Tall doors and tall windows are hardwired to your brain to give you bigger thinking,” says Antonio Ocana, the clinical director of Pasithea’s L.A. office.

The tiny window in the waiting room—a feature typical of the other offices in the Sunset Medical Tower, or so I’m told—has been scrapped in favor of a cascading frosted glass.

“It’s to bring in more natural light,” says Daniela Amador, the 20-something interior designer of the clinic. And the removal of sharp corners in the waiting room in favor of curves, she says, “was a representation of the cycle of life.”

In that sense, the Pasithea clinic feels less like a psychiatric office where they administer intravenous dissociative anesthetics and more like a desert sanctuary.

“There are two types of [ketamine] clinics or two types of vibes so to speak,” says Manuel Hoyer, Pasithea’s VP of Growth and Marketing. “One is a very hippy-esque, mom-and-pop shop that to a degree feels very aligned with the movement around psychedelics that’s not quite super credible for folks seeking out something medically backed. And on the other side of the spectrum you have more dentist-office-like spaces that are not giving away the sense that this is an innovative treatment.”

This distinction is important considering Pasithea is hardly the first ketamine clinic to open brick and mortar in L.A. In fact, it’s not even the fifteenth. Since 2014, when anesthesiologist Steven Mandel, who co-founded Ketamine Clinics Los Angeles, began using ketamine for off-label purposes to treat depression and other mental health disorders, Los Angeles has seen more than 1,000% increase in the number of clinics, based on the current number of ketamine clinics listed on Yelp. The current market size of this industry is estimated at $900 million. It helps too that in 2019, the FDA approved a version of ketamine called esketamine for mental health treatment. Under the brand name Spravato, the antidepressant is administered via nasal spray.

At Pasithea, the price per session for IV ketamine treatment is $700.

“Spravato will be offered as well starting next month,” says Hoyer. They recommend starting with six sessions of IV ketamine that are typically undergone anywhere between one to three weeks. Other ketamine clinics in Los Angeles have a similar protocol but range in price between $400 and $700 per infusion. Which is to say, Pasithea, if anything, is on the higher end of the spectrum.

But such is the price of healing inside a facility that looks less like a medical office and more like a cream-hued fantasy dream. Similar in sensibility, as Hoyer says, to “Santa Monica’s Proper Hotel,” with its sandy palette that alludes to a beach setting.

In recent years or, at least since 2020, much of the reporting on ketamine clinics has, inadvertently, drawn attention to the “vibe” of the facilities. Last year, when reporting on Field Trip, a ketamine clinic in Santa Monica that opened in September 2020, dot LA’s Keerthi Vedantam noted that, “the clinic is outfitted with mid-century furniture, fluffed-up cushions and shaggy rugs, almost like an Architectural Digest spread came to life.”

In her story from 2020 on the mainstreamification of ketamine therapy, the New Yorker’s Emily Witt wrote that the “decorative touches'' of Field Trip’s New York office, “are spa-like: white rugs, fiddle-leaf figs, electric candles inside glass-paned lanterns.” Adding that, “The aesthetic seems based on the assumption that, when a company hopes to take a formerly taboo practice mainstream, a West Elm interior can go a long way.”

Additionally, Field Trip has been described as, “not your average doctor’s office.” The waiting room, writes Sara Spruch-Feiner for Coveteur, “looks more like your chicest friend’s living room, with plenty of natural sunlight, a tactile moss wall, and aesthetically minded furniture.”

All of which is a far cry from the ketamine clinics of yore, which one Redditor described as being “in the back of a [P]olish pharmacy next to a kebab shop,” or “full of incense and pretty psychedelic.”

According to Ocana, to be eligible for ketamine therapy inside Pasithea’s lush, contemporary facility, a patient has to have already tried at least two different SSRIs. Which is important considering IV administered ketamine is not currently FDA approved for any psychiatric indication.

“There are a number of FDA-approved medications and evidence-based treatments for depression, including medications, TMS [transcranial magnetic stimulation], ECT [electroconvulsive therapy] and evidence based psychotherapy,” says Charles Nemeroff, the chair of Department of Psychiatry and Behavioral Sciences at the University of Texas in Austin. “Where ketamine should fall in the treatment algorithm is unclear at this time. I see many patients with treatment-resistant depression who are immediately sent to a ketamine clinic before other well-established treatments have been tried.”

To that end, Nemeroff says, only a small minority of the clinics you are referring to adhere to these recommendations.

“Unfortunately, if you have the funds to pay for a treatment, you can easily receive it,” he adds.

Which is exactly the sort of clientele Pasithea hopes to attract with its palatial motif. According to VP of Operations Chirstian Pedrini, their primary demographic is “people between the age of 25 and 45, successful, either corporate or execs, probably tech and working in the entertainment business, basically people working in high stress environments.” Adding that for these types of people, “the thing you always need to take into account with these psychedelic treatments, is setting is really important.” Hence the floor-to-ceiling wall installation in the waiting room, backlit and ornamented with white vases and beach dried palm spears. Or the white leather phlebotomy chairs. Or the vases and wall art sprinkled throughout the facility, that look as though they’ve been picked out of a CB2 catalog.

Such is the inevitable result of ketamine going mainstream and backed by venture capital. In fact, these days, you don’t even have to go looking for ketamine therapy to find it. Per Rolling Stone’s recent report on the telemedicine company Peak, they’re pushing ketamine therapy via TikTok. Pasithea, at least, who does offer at-home ketamine therapy, does require that a medical professional administer the IV.

Ultimately, says Amador, her goal when designing the Pasithea clinic was to redefine what a doctor’s office could be — to demolish that feeling most people get when they arrive inside the typically aseptic waiting area replete with old gossip rags.

“We want the opposite,” she says. “We want the patient to feel at home.”

Netflix Doubles Down on LA

🔦 Spotlight

Hey Los Angeles.

Goodbye Coachella, hello Stagecoach. The desert doesn’t stay quiet for long, and neither does LA’s entertainment machine.

This week, that momentum showed up in a more permanent way.

Netflix is expanding its footprint in Los Angeles with a major move to take over and invest in Radford Studio Center, a historic production lot in Studio City. The company is planning a long-term transformation of the site, with upgrades to soundstages, production offices, and infrastructure designed to support the next generation of film and television production.

It’s a notable shift in a moment when production has been under pressure in California, with studios increasingly looking outside the state for cost advantages. Netflix going deeper in LA, and specifically into a legacy studio lot, signals a different kind of commitment. Not just to content, but to where that content actually gets made.

And it comes at a time when the streaming wars have matured. Growth is harder, budgets are tighter, and the focus has shifted from scale at all costs to efficiency and control. Owning or operating more of the production environment gives Netflix tighter control over timelines, costs, and output.

For Los Angeles, it’s a reminder of what still anchors the city. Even as AI, defense tech, and infrastructure startups continue to rise, entertainment remains one of the few industries where LA isn’t just competitive, it’s foundational.

Different headlines each week, but a consistent theme underneath them. Whether it’s power, autonomy, or content, the companies that matter are investing in the layers they don’t want to outsource.

And in this case, that layer is Hollywood itself.

Below are this week’s venture deals, fund announcements, and acquisitions across LA 👇


🤝 Venture Deals

    LA Venture Funds

    • UP Partners and Calm Ventures participated in Reliable Robotics’ $160M funding round, backing the autonomous aviation company as it advances pilotless flight technology for cargo and passenger aircraft. The round included a mix of new and existing investors, and the company plans to use the capital to accelerate certification efforts and expand deployment of its autonomous systems across commercial aviation. - learn more
    • Blue Heron Ventures participated in Tava Health’s $40M Series C, backing the company as it expands its tech-enabled mental health platform into a more integrated, full-stack system for providers, employers, and health plans. The round was led by Centana Growth Partners with participation from existing investors, and the company plans to use the funding to roll out new AI-powered tools and broaden access to care while reducing administrative friction across the system. - learn more
    • Vamos Ventures participated in Zócalo Health’s $15M Series A, backing the company as it scales its tech-enabled, community-based primary care model focused on high-need and underserved populations. The round was led by .406 Ventures with participation from existing and new investors, and the company plans to use the funding to expand its clinics and deepen partnerships with Medicaid programs as demand for accessible care grows. - learn more

    LA Exits
    • Studio71 has been acquired by Fixated as part of a broader deal in which German media company ProSiebenSat.1 sold its North American creator business, giving Fixated a large-scale network of creators and podcast operations and significantly expanding its footprint as it continues an aggressive roll-up strategy in the creator economy. The move signals continued consolidation in the space, with Fixated building a more vertically integrated platform across talent management, content production, and distribution. - learn more
    • Bonsai Health has been acquired by ModMed, bringing its AI-powered patient engagement platform into a broader healthcare software ecosystem. The deal is aimed at integrating Bonsai’s “agentic AI” capabilities into ModMed’s platform to automate patient outreach, fill care gaps, and improve scheduling across a network of nearly 50,000 providers. - learn more

      Download the dot.LA App

      A $26M Push Into Power in LA

      🔦 Spotlight

      Hello, Los Angeles.

      Coachella Weekend 2 is here, which usually means LA is either heading back to the desert or happily staying put this time around. Back in the city, the focus this week is less about music infrastructure and more about something far more critical, power.

      That’s where this week’s news comes in.

      Critical Loop, a Los Angeles-based energy startup, raised a $26 million Series A to tackle one of the least talked about bottlenecks in tech right now, grid interconnection. In simple terms, it’s the process of getting power to where it’s needed, and increasingly, that process is too slow to keep up.

      Critical Loop is building modular microgrid systems that can be deployed in days instead of years, giving industrial operators, data centers, and other energy-heavy users faster access to power without waiting on traditional grid upgrades. The round was led by Conifer Infrastructure Partners and Hanover, with participation from Better Ventures, Climate Capital, Adapt Nation Capital, and Cyrus Ventures.

      The timing here matters. Between AI infrastructure demands, electrification, and a broader push toward domestic energy resilience, power is quickly becoming a gating factor for growth. You can build the data center, the factory, or the next big thing, but none of it works if you can’t turn it on.

      That’s what makes companies like Critical Loop worth watching. They’re not building the flashiest part of the stack, but they’re solving for the piece everything else depends on.

      And in a city that knows a thing or two about scaling ambition quickly, that might be the most important layer of all.

      Below are this week’s fund announcements across LA 👇


      🤝 Venture Deals

      LA Venture Funds

      • Anthos Capital participated in Wealth.com’s $65M Series B, backing the AI-powered estate and tax planning platform as it scales across financial institutions. The oversubscribed round included new investors like Titanium Ventures and Pruven Capital alongside existing backers, and the company plans to use the funding to expand product development, pursue acquisitions, and grow its enterprise footprint as demand rises for AI-driven wealth management solutions. - learn more
      • Anamika Ventures participated in Sage Haven’s $3M pre-seed round, backing the AI-powered messaging and calling app designed to create a safer communication environment for kids. The round was led by Anamika Ventures alongside Fabric Ventures and a group of early-stage investors, as the company launches a platform focused on preventing cyberbullying through real-time AI moderation and parent oversight tools. - learn more
      • MANTIS Venture Capital participated in Factory’s $150M Series C, backing the AI startup as it builds autonomous software engineering systems for enterprise teams. The round was led by Khosla Ventures and included firms like Sequoia Capital, Blackstone, Insight Partners, and NEA, valuing the company at $1.5 billion. Factory plans to use the funding to invest further in product development and global expansion as demand grows for AI-driven tools that can automate large portions of the software development process. - learn more
      • Rebel Fund participated in Uplane’s $4.5M seed round, backing the AI startup as it looks to replace traditional marketing agencies with a platform that automates ad creation, testing, and budget optimization. The round was led by Play Ventures with participation from Y Combinator, 20VC, and Multimodal Ventures, and the company says its technology can improve return on ad spend by automating performance marketing workflows. - learn more
      • Alexandria Venture Investments and Presight Capital participated in Alloy Therapeutics’ $40M Series E, backing the biotech infrastructure company as it scales its AI-powered platform for drug discovery and development. The round included a mix of new investors like 8VC and JIC Venture Growth Investments alongside returning backers, valuing the company at $1 billion and underscoring continued interest in platforms that combine AI, data, and lab services across the biopharma lifecycle. - learn more
      • Finality Capital Partners participated in HYFIX’s $15M seed round, backing the semiconductor startup as it builds American-made chips designed to power drones and autonomous robots. The round was led by Craft Ventures with participation from Catapult Ventures, Multicoin Capital, and Sky Dayton, and the company is developing an integrated system-on-a-chip to replace fragmented hardware stacks and reduce reliance on foreign components. - learn more
      • Rainfall Ventures participated in Stendr’s $5.4M pre-seed round, backing the Norwegian defense tech startup as it builds an AI-native platform for drone detection and counter-drone operations. The round was co-led by Rainfall alongside ACME Capital and Skyfall, with additional participation from Antler, StartupLab, and other early-stage investors, and the company plans to use the funding to accelerate development of its multi-sensor technology and expand engineering capabilities. - learn more
      • Slauson & Co. participated in Slate Auto’s $650M funding round, backing the EV startup as it works to bring a lower-cost electric pickup truck to market. The round was led by TWG Global and comes as the Bezos-backed company prepares to begin production, targeting a more affordable segment of the EV market with a customizable truck expected to launch later this year. - learn more
      • Navitas Capital co-led Primepoint’s $10M seed round, backing the AI startup as it builds a platform that reads and connects complex construction drawings to streamline project workflows. The round also included investors like Penny Jar Capital, NextView Ventures, GS Futures, and Aglaé Ventures, and the company plans to use the funding to expand its platform and grow adoption among large commercial contractors. - learn more
      • Alexandria Venture Investments participated in Neomorph’s $100M Series B, backing the biotech company as it advances its molecular glue degrader platform targeting previously undruggable diseases. The round was led by Deerfield Management with participation from Regeneron Ventures, Longwood Fund, and Binney Street Capital, and the company plans to use the funding to support ongoing clinical trials and expand its broader drug development pipeline. - learn more

      Download the dot.LA App

      Hermeus Moves In. Uber Lines Up. LA Wins.

      🔦 Spotlight

      Hello, Los Angeles.

      This week’s transportation news says a lot about where LA is headed and who wants to build here.

      Start with Hermeus, which hit a $1 billion valuation after raising $350 million as it works on high-speed aircraft for defense applications. More notably for Los Angeles, the company is moving its headquarters to El Segundo, adding to the region’s growing aerospace and defense cluster. The round was led by Khosla Ventures, with participation from returning backers including Canaan Partners, Founders Fund, RTX Ventures, Bling Capital, and In-Q-Tel, along with new investors including Cox Enterprises, Socium Ventures, Destiny Tech100, Georgia Tech Foundation, 137 Ventures, and GSBackers.

      Then there’s Uber, which made two separate autonomous vehicle announcements that both put Los Angeles in the rollout map.

      The first is a partnership with Zoox, Amazon’s autonomous vehicle company. Uber said the service is expected to launch in Las Vegas in summer 2026 and then come to Los Angeles by mid-2027, giving riders the option to match with a Zoox robotaxi through the Uber app.

      The second is a new deal with MOIA America, which plans to deploy autonomous ID. Buzz vehicles on the Uber platform in Los Angeles by the end of 2026.

      Taken together, the message is pretty straightforward: LA is not just watching the future of transportation take shape, it is increasingly being used as the place to test it, scale it, and sell it. Hermeus is bringing its headquarters here as defense aviation regains momentum. Uber is lining up autonomous partners with Los Angeles as a target market. Different companies, different timelines, same conclusion: a meaningful share of the next transportation cycle is being built with LA in mind.

      Below are this week’s venture deals, fund announcements, and acquisitions across LA.


      🤝 Venture Deals

      LA Companies
      • PeakMetrics raised a $6M Series A to scale its AI-powered narrative intelligence platform, which helps organizations track how information spreads online and identify risks from misinformation and coordinated campaigns. The round was led by Moneta Ventures with participation from Techstars, Parameter Ventures, VITALIZE Venture Capital, and Gurtin Ventures, and the company plans to use the funding to enhance its real-time detection capabilities and expand adoption across enterprise and government customers. - learn more
      • Hybron raised a $25M seed round to scale its advanced carbon fiber composite manufacturing technology, which aims to produce high-performance components faster and at lower cost than traditional methods. The round was led by Marque Ventures with participation from a mix of venture firms and strategic investors, and the company plans to use the funding to expand manufacturing capacity, grow its team, and support increasing demand from aerospace and defense programs. - learn more

      LA Venture Funds

      • Emmeline Ventures participated in Osteoboost’s $8M funding round, backing the company as it expands access to its FDA-cleared wearable designed to treat low bone density in postmenopausal women. The round was led by Ambit Health Ventures with participation from Disrupt Health Impact Fund and others, and the company plans to use the capital to scale manufacturing, expand clinical research, and grow commercial adoption. - learn more
      • Bonfire Ventures led Juno’s $12M seed round, backing the AI-powered tax preparation platform as it aims to automate up to 90% of the manual work in tax filing for accounting firms. The round included participation from Impression Ventures and Xfund, and the company says its software can significantly reduce preparation time while keeping CPAs in the loop for review and advisory work. - learn more
      • Alexandria Venture Investments participated in Sidewinder Therapeutics’ $137M Series B, which will help fund the company’s push to bring its precision bispecific ADC cancer programs into the clinic. The round was co-led by Frazier Life Sciences and Novartis Venture Fund, and Sidewinder said it expects to advance its lead program into clinical development in 2027. - learn more
      • Slauson & Co. participated in Flora Fertility’s $5M seed round, backing the company as it builds what it describes as an individually owned fertility insurance platform that is not tied to an employer. The round was led by ManchesterStory, and Flora plans to use the funding to scale a model aimed at making fertility coverage more portable and accessible for consumers. - learn more
      • Mucker Capital participated in Fastrflow’s $375K early funding round, backing the startup as it builds a screen-aware AI copilot designed to assist students and professionals directly within their workflows. The company is focused on creating an assistant that can understand what’s on a user’s screen in real time to provide contextual help, positioning itself as a more integrated alternative to traditional standalone AI tools. - learn more

      LA Exits

      • Modern Animal has been acquired by Chewy, giving the pet e-commerce giant a much bigger physical veterinary footprint as it expands deeper into healthcare. The deal brings Chewy an additional 29 clinics, 24/7 virtual care, and a membership-based model, and is expected to grow Chewy Vet Care from 18 to 47 locations nationwide while adding more than $125 million in annualized run-rate revenue. - learn more
      • Honk has been acquired by Frontenac, with the Los Angeles roadside assistance software company simultaneously completing an add-on acquisition of CurbsideSOS as part of the deal. The combination is meant to scale Honk’s platform for roadside assistance, towing, and accident management, with former Grubhub executives including Adam DeWitt, Matt Maloney, and Eric Ferguson joining the company to lead its next phase of growth. - learn more

      Download the dot.LA App

      RELATEDEDITOR'S PICKS
      Trending